BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study. (Record no. 28420544)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02589 a2200685 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517215752.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201910s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1527-7755 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1200/JCO.2017.77.2285 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Fasching, Peter A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20191003 |
245 00 - TITLE STATEMENT | |
Title | BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
Date of publication, distribution, etc. | 08 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 2281-2287 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | BRCA1 Protein |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | BRCA2 Protein |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bevacizumab |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclophosphamide |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Docetaxel |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Epirubicin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genotype |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Germ-Line Mutation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoadjuvant Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor, ErbB-2 |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Triple Negative Breast Neoplasms |
General subdivision | blood |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Loibl, Sibylle |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hu, Chunling |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hart, Steven N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shimelis, Hermela |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Moore, Raymond |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schem, Christian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tesch, Hans |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Untch, Michael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hilfrich, Jörn |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rezai, Mahdi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gerber, Bernd |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Costa, Serban Dan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Blohmer, Jens-Uwe |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fehm, Tanja |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Huober, Jens |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Liedtke, Cornelia |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Weinshilboum, Richard M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wang, Liewei |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ingle, James N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Müller, Volkmar |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nekljudova, Valentina |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Weber, Karsten E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rack, Brigitte |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rübner, Matthias |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | von Minckwitz, Gunter |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Couch, Fergus J |
773 0# - HOST ITEM ENTRY | |
Title | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
Related parts | vol. 36 |
-- | no. 22 |
-- | p. 2281-2287 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1200/JCO.2017.77.2285">https://doi.org/10.1200/JCO.2017.77.2285</a> |
Public note | Available from publisher's website |
No items available.